Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

NCT04296864 is registered in ClinicalTrials.gov with Andover Eye Associates as lead sponsor.

NCT NCT04296864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04296864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
Lead sponsor
Andover Eye Associates
Phase
Phase 2
Overall status
Unknown status
Start date
February 10, 2020
Completion date
January 31, 2025
Enrollment
42 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

atopic keratoconjunctivitis